The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
Ribonucleases are a superfamily of RNA-cleaving enzymes that can be cytotoxic since the cleavage of RNA makes its information indecipherable. Ranpirnase is a novel ribonuclease which preferentially degrades tRNA, thus leading to an inhibition of protein synthesis and, ultimately, to cytostasis and c...
Main Authors: | Luciano Mutti, Giovanni Gaudino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-12-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/110 |
Similar Items
-
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011-12-01) -
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model
by: Eric G. Romanowski, et al.
Published: (2022-12-01) -
Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro
by: Todd G. Smith, et al.
Published: (2020-02-01) -
Ribonucleases as potential therapeutic agents
by: Masoume Vakili-Azghandi, et al.
Published: (2021-03-01) -
Structural and Functional Differences between Homologous Bacterial Ribonucleases
by: Vera Ulyanova, et al.
Published: (2022-02-01)